Implantable Device Data (Pacemakers/ICD)
Buy and sell implantable device data (pacemakers/icd) data. Pacemaker logs, ICD shock records, lead impedance trends — cardiac device AI needs real implant telemetry.
No listings currently in the marketplace for Implantable Device Data (Pacemakers/ICD).
Find Me This Data →Overview
What Is Implantable Device Data (Pacemakers/ICD)?
Implantable device data encompasses telemetry, diagnostic logs, and performance records from cardiac implants such as pacemakers and implantable cardioverter defibrillators (ICDs). This data includes pacemaker activity logs, ICD shock records, lead impedance trends, arrhythmia detection events, and remote monitoring readings from cardiac rhythm management devices. AI developers, medical device manufacturers, and clinical researchers purchase this real implant telemetry to train algorithms for device optimization, predictive maintenance, and improved patient outcomes. The global implantable medical devices market reached USD 147.6 billion in 2025 and is projected to grow to USD 217.5 billion by 2034. Within this broader market, implantable cardiac rhythm management (CRM) devices—including pacemakers and ICDs—represent a specialized but high-value segment, with the CRM market alone anticipated to reach USD 23.5 billion by 2034. Remote monitoring of these devices is becoming standard clinical practice, generating continuous streams of actionable device data.
Market Data
USD 147.6 Billion
Global Implantable Medical Devices Market Size (2025)
Source: IMARC Group
USD 217.5 Billion
Projected Market Size (2034)
Source: IMARC Group
USD 23.5 Billion
Implantable CRM Market Projection (2034)
Source: iHealthcare Analyst
USD 31.14 Billion
Active Implantable Devices Market (2025)
Source: Market Data Forecast
4.27%
Global Market CAGR (2026-2034)
Source: IMARC Group
Who Uses This Data
What AI models do with it.do with it.
AI and Algorithm Development
Cardiac device manufacturers and AI research labs use implant telemetry data to train machine learning models for arrhythmia detection, device failure prediction, and therapy optimization in ICDs and pacemakers.
Remote Patient Monitoring Systems
Wireless monitoring platforms and hemodynamic monitoring devices leverage real device data to enable early detection of complications and support continuous remote surveillance of implant performance.
Clinical Validation and R&D
Leading manufacturers such as Medtronic, Abbott, and Boston Scientific conduct long-term clinical testing and validation studies using implant data to enhance device features including leadless pacemakers and extravascular ICDs.
Regulatory and Efficacy Studies
Health systems and research institutions analyze device telemetry to support regulatory submissions, real-world evidence generation, and clinical outcome documentation for arrhythmia and heart failure management.
What Can You Earn?
What it's worth.worth.
Subscription Data Feed: Device Telemetry Datasets (per record/month)
Varies
Pricing depends on data richness, patient cohort size, longitudinal depth, and exclusivity. ICD shock records and lead impedance trends command premium rates due to clinical criticality.
Real-World Implant Registries
Varies
Large-scale datasets with multi-year follow-up and diverse device types attract higher valuations from manufacturers and AI research organizations.
Remote Monitoring Logs (CRM Devices)
Varies
Continuous or frequent monitoring data from pacemakers and ICDs is valued for its temporal resolution and actionable event density, affecting pricing tier.
What Buyers Expect
What makes it valuable.valuable.
Diagnostic Accuracy
Device logs must accurately capture arrhythmia events, therapy deliveries (ICD shocks), and lead impedance changes with precise timestamps and validated clinical correlates.
Data Completeness and Longitudinal Continuity
Buyers require uninterrupted or clearly documented monitoring periods, minimal data gaps, and comprehensive device parameter datasets to train robust algorithms.
Clinical Validation and Annotation
Data should be annotated with clinical outcomes (e.g., arrhythmia type, patient status, device model, implant indication) to support supervised learning and regulatory-grade evidence.
Privacy and Regulatory Compliance
All patient identifiers must be removed or de-identified according to HIPAA and relevant medical device regulations; data provenance and consent documentation are mandatory.
Device Diversity and Real-World Heterogeneity
Datasets spanning multiple device manufacturers, implant types (single-chamber, dual-chamber, subcutaneous ICDs, leadless pacemakers), and patient populations enhance model generalizability.
Companies Active Here
Who's buying.buying.
Invests heavily in R&D and long-term clinical validation of next-generation devices including leadless pacemakers and remote monitoring systems using real implant telemetry.
Focuses on innovation in cardiac rhythm management devices and conducts rigorous testing and safety validation using implant data for arrhythmia detection and therapy optimization.
Engages in R&D and clinical validation to develop advanced implantable devices, including extravascular ICDs and remote monitoring solutions backed by device telemetry analysis.
Acquire implant telemetry datasets to train machine learning algorithms for predictive maintenance, arrhythmia classification, and early detection of device-related complications.
FAQ
Common questions.questions.
What specific data types fall under implantable device data?
Core data types include pacemaker activity logs, ICD shock records and therapy events, lead impedance trends, arrhythmia detection records, heart rhythm monitoring data, device parameter settings, battery status, and telemetry readings from remote monitoring systems. This encompasses both diagnostic event data and continuous physiologic measurements.
Why is implant telemetry valuable for AI development?
Real implant telemetry provides authentic, clinically validated data showing how devices respond to actual patient arrhythmias and hemodynamic changes. This enables training of machine learning models for accurate arrhythmia classification, device malfunction prediction, and personalized therapy optimization—tasks that simulated data cannot fully replicate.
Which markets are driving demand for this data?
The implantable medical devices market is growing at 4.27% annually and reached USD 147.6 billion in 2025. The cardiac rhythm management segment alone is projected to hit USD 23.5 billion by 2034. Growth drivers include rising chronic disease prevalence, aging populations, technological advances in leadless devices, and widespread adoption of remote monitoring systems.
What compliance and privacy considerations apply?
All data must be de-identified and compliant with HIPAA and medical device regulations. Patient identifiers must be removed, and data provenance documentation and patient consent records are mandatory. Buyers—especially regulated medical device manufacturers—verify compliance before licensing datasets for clinical validation or algorithm development.
Sell yourimplantable device data (pacemakers/icd)data.
If your company generates implantable device data (pacemakers/icd), AI companies are actively looking for it. We handle pricing, compliance, and buyer matching.
Request Valuation